Global Respiratory Inhalers Market

Global Respiratory Inhalers Market
GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND
OPPORTUNITY ANALYSIS, 2018-2026
REPORT DESCRIPTION
Global Respiratory Inhalers Market – Overview
Respiratory diseases such as bronchitis, asthma, allergic rhinitis, pneumonia and sinusitis can significantly
curtail the physical activities of the individual. The symptoms associated with both mild and severe
manifestations of these respiratory conditions include coughing, wheezing, chest pain, respiratory distress,
shortness of breath, congestion, and even death in severe cases. These conditions lead to substantial
morbidity and causes large cost of burden to the society. Increasing air pollution can severely affect
respiratory health of children as well as adults. Various studies conducted have shown the ill effects of air
pollution that can exacerbate existing respiratory conditions such as asthma, COPD, and upper airway
allergies. According to the Forum of International Respiratory Societies, in 2013, young children and
infants were especially susceptible to respiratory diseases. Around 9.0 million children under the age of 5
years die per year and the common thing in them is the presence of lung diseases. Increase in evidences
through such studies suggests that the exposure to certain type of air pollutants contributes to the onset of
asthma. However, studies related to the exacerbation of pre-acquired and existing asthma are more
prevalent as they provide favorable conditions to study.
REPORT DESCRIPTION
Global Respiratory Inhalers Market – Taxonomy
●
●
●
In September, GlaxoSmithKline plc, received approval for Trelegy Ellipta. Trelegy Ellipta, is the first
once-daily use inhaler triple therapy (i.e. combination of 3 active molecules in a single inhaler) for the
treatment of Chronic Obstructive Pulmonary Disease (COPD).
In April, 2016, AstraZeneca received approval for Bevespi Aerosphere, the first product which uses
AstraZeneca’s Co-Suspension Technology. The technology enables more than one medicine delivery
from a single MDI.
In 2010, around 115,000 patients were hospitalized due to sever chronic obstructive pulmonary disease,
which cost the NHS around US$ 367.85 Mn and is expected to increase over the forecast period. Sandoz
launched an innovative respiratory inhaler AirFluSal Forspiro in the UK in 2015, to capitalize on the
highly lucrative market in the region.
Get PDF Brochure @
https://www.coherentmarketinsights.com/insight/request-pdf/227
REPORT DESCRIPTION
Global Respiratory Inhalers Market – Key Players
•
•
•
•
•
•
Beximco Pharmaceuticals Ltd.,
Boehringer Ingelheim GmbH,
Cipla Ltd., GlaxoSmithKline plc,
Koninklijke Philips N.V., Merck & Co., Inc.,
OMRON Healthcare Europe B.V.,
PARI Medical Holding and Teva Pharmaceutical Industries Ltd.
Read More @
https://www.coherentmarketinsights.com/market-insight/respiratory-inhalers-market-227
ABOUT COHERENT MARKET INSIGHTS
ABOUT US
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its
plethora of clients achieve transformational growth by helping them make critical business decisions. We are
headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players
from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help
businesses around the globe deliver practical and lasting results through various recommendations about
operational improvements, technologies, emerging market trends and new working methods. We offer both
customized and syndicated market research reports that help our clients create visionary growth plans to
provide traction to their business. We meticulously study emerging trends across various industries at both the
global and regional levels to identify new opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
MARKET INTELLIGENCE SERVICES
CUSTOMIZED RESEARCH
SYNDICATED RESEARCH
CONSULT STUDIES
COUNTRY SPECIFIC STUDIES
ABOUT CMI
SECTOR
COVERAGE
BIOTECHNOLOGY
MEDICAL DEVICES




CLINICAL
DIAGNOSTIC
MEDICAL IMAGING
Global Leading Equipment and System Manufacturers
Component Providers and System Integrators
Distributors, Retailors and Value Added Resellers
Healthcare IT Solutions Developers
Marketing Consultancies and the Advertising Industry
 Private and Government organization
 Outsourcing Companies
 Universities and Business Schools.
HEALTHCARE IT
PHARMACEUTICAL
ABOUT US
KEY STATS
100
+
150+
RESEARCH
SOLUTIONS
FEASIBILITY
STUDIES
GLOBAL
REPORTS
Insights Published Per Year
Consulting Projects Till
Date
125+
Clients Worldwide Per Year
110+
COUNTRY
ANALYSIS
CONSULT
PROJECTS
SURVEY
RESEARCH
EXCEL
FORECAST
DATABASE
COMPETITIVE
ASSESSMENT
TECHNOLOGY
SNIPPETS
Analysts and Contract
Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including
chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in
the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various
industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely
designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed
markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein.
THANK YOU
To know more about us, visit our website:
www.coherentmarketinsights.com
For sales queries or new topics email us on:
sales@coherentmarketinsights.com
For other queries contact:
Mr. Shah
(Manager - Business Development)
Coherent Market Insights
sales@coherentmarketinsights.com
+1-206-701-6702

Respiratory diseases such as bronchitis, asthma, allergic rhinitis, pneumonia and sinusitis can significantly curtail the physical activities of the individual.